Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 11:21AM ET
3.14
Dollar change
+0.09
Percentage change
2.95
%
IndexRUT P/E- EPS (ttm)-0.74 Insider Own17.19% Shs Outstand70.69M Perf Week2.95%
Market Cap222.03M Forward P/E- EPS next Y-0.20 Insider Trans0.15% Shs Float58.55M Perf Month-8.45%
Income-52.34M PEG- EPS next Q-0.23 Inst Own63.68% Short Float6.26% Perf Quarter-7.65%
Sales0.39M P/S569.31 EPS this Y5.63% Inst Trans2.24% Short Ratio17.50 Perf Half Y-19.49%
Book/sh1.24 P/B2.53 EPS next Y71.72% ROA-34.98% Short Interest3.67M Perf Year10.18%
Cash/sh1.50 P/C2.10 EPS next 5Y- ROE-47.57% 52W Range2.40 - 4.14 Perf YTD-2.48%
Dividend Est.- P/FCF- EPS past 5Y18.87% ROI-39.49% 52W High-24.13% Beta0.71
Dividend TTM- Quick Ratio9.55 Sales past 5Y275.67% Gross Margin-307.61% 52W Low30.83% ATR (14)0.20
Dividend Ex-Date- Current Ratio9.55 EPS Y/Y TTM3.63% Oper. Margin-15134.64% RSI (14)50.11 Volatility7.67% 6.55%
Employees40 Debt/Eq0.52 Sales Y/Y TTM-73.93% Profit Margin-13362.21% Recom1.00 Target Price8.00
Option/ShortYes / Yes LT Debt/Eq0.51 EPS Q/Q-32.84% Payout- Rel Volume0.32 Prev Close3.05
Sales Surprise-98.36% EPS Surprise-335.64% Sales Q/Q205.88% EarningsMar 08 BMO Avg Volume209.60K Price3.14
SMA203.58% SMA50-7.46% SMA200-9.42% Trades Volume21,243 Change2.95%
Date Action Analyst Rating Change Price Target Change
Dec-21-23Initiated BTIG Research Buy $11
Oct-13-23Initiated Oppenheimer Outperform $8
Apr-20-21Downgrade Cantor Fitzgerald Buy → Neutral $4
Mar-03-21Downgrade RBC Capital Mkts Outperform → Sector Perform $5
Dec-02-20Downgrade JMP Securities Mkt Outperform → Mkt Perform
Dec-02-20Downgrade Citigroup Buy → Neutral $10 → $4
Sep-04-19Initiated RBC Capital Mkts Outperform $12
Apr-20-18Initiated Ladenburg Thalmann Buy $27
Mar-17-24 05:19PM
Mar-08-24 08:00AM
Feb-28-24 08:00AM
Feb-06-24 08:00AM
Dec-01-23 07:30AM
12:00PM Loading…
Nov-09-23 12:00PM
08:48AM
Nov-05-23 07:15PM
Nov-03-23 08:00AM
Oct-19-23 10:44AM
Oct-18-23 08:00AM
Oct-10-23 08:00AM
Sep-29-23 03:16PM
Sep-26-23 07:30AM
Sep-20-23 07:30AM
08:00AM Loading…
Aug-30-23 08:00AM
Aug-15-23 09:38PM
Aug-04-23 09:15AM
08:00AM
Aug-01-23 08:00AM
Jul-31-23 09:29PM
Jul-02-23 10:00AM
Jun-28-23 08:00AM
Jun-26-23 08:00AM
May-22-23 06:43AM
May-05-23 08:45AM
07:30AM
May-01-23 06:00AM
Apr-27-23 02:30PM
Apr-12-23 12:00PM
06:51AM Loading…
Apr-11-23 06:51AM
Apr-10-23 08:00AM
Mar-15-23 06:21AM
Mar-13-23 08:00AM
Mar-09-23 08:00AM
Mar-08-23 08:00AM
Feb-28-23 08:00AM
Feb-08-23 08:00AM
Jan-22-23 07:37AM
Jan-05-23 08:00AM
Dec-02-22 10:00AM
Nov-17-22 07:23AM
Nov-08-22 08:00AM
Oct-18-22 08:57AM
Sep-27-22 08:00AM
Sep-26-22 09:21AM
Sep-07-22 08:00AM
Aug-14-22 10:40AM
Aug-09-22 08:00AM
Jun-10-22 07:41AM
Jun-06-22 08:00AM
May-11-22 06:55AM
May-10-22 08:00AM
Apr-26-22 07:17AM
Apr-08-22 08:00AM
Mar-15-22 08:00AM
Mar-07-22 01:06PM
Mar-04-22 08:00AM
Feb-28-22 01:51PM
Feb-08-22 08:00AM
Jan-04-22 08:01AM
Jan-03-22 07:25AM
06:30AM
Nov-10-21 08:30AM
Nov-05-21 12:03PM
Oct-07-21 08:30AM
Sep-07-21 08:00AM
Sep-06-21 12:58PM
Aug-16-21 08:00AM
Jul-08-21 04:30PM
Jul-07-21 08:00AM
Jul-06-21 07:01AM
Jun-04-21 08:00AM
May-26-21 08:00AM
May-24-21 07:52AM
May-21-21 08:46AM
May-20-21 09:29AM
May-13-21 04:05PM
May-12-21 08:00AM
May-07-21 08:42AM
Apr-30-21 11:37AM
Apr-20-21 08:00AM
Apr-19-21 09:16AM
08:00AM
Mar-30-21 08:00AM
Mar-20-21 04:51AM
Mar-16-21 08:39AM
Mar-15-21 08:00AM
Mar-10-21 03:44AM
Mar-03-21 07:46AM
07:40AM
07:00AM
07:00AM
Jan-15-21 02:22AM
Dec-16-20 07:00AM
12:30AM
Dec-02-20 11:38AM
11:30AM
09:52AM
07:35AM
Ovid Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
LEVIN JEREMY MCEOMar 18 '24Buy2.7618,24850,3643,616,715Mar 20 05:22 PM